Diane Copeland

1.2k total citations
15 papers, 981 citations indexed

About

Diane Copeland is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Diane Copeland has authored 15 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Organic Chemistry and 7 papers in Epidemiology. Recurrent topics in Diane Copeland's work include Lysosomal Storage Disorders Research (11 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Trypanosoma species research and implications (5 papers). Diane Copeland is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Trypanosoma species research and implications (5 papers). Diane Copeland collaborates with scholars based in United States, Netherlands and Argentina. Diane Copeland's co-authors include Cecilia Avila, Moshe Mazor, Waldo Sepúlveda, Roberto Romero, John Williams, Seng H. Cheng, Johannes M. F. G. Aerts, John Marshall, James A. Shayman and Ronald K. Scheule and has published in prestigious journals such as PLoS ONE, Hepatology and Analytical Biochemistry.

In The Last Decade

Diane Copeland

15 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diane Copeland United States	12	436	431	309	203	184	15	981
Janice Carneiro Coelho Brazil	18	639 1.5×	263 0.6×	296 1.0×	141 0.7×	66 0.4×	72	1.1k
Damon Getman United States	21	224 0.5×	446 1.0×	408 1.3×	50 0.2×	41 0.2×	40	1.4k
Toru Taniguchi Japan	18	140 0.3×	125 0.3×	208 0.7×	41 0.2×	95 0.5×	47	781
Talar Kechichian United States	22	82 0.2×	538 1.2×	224 0.7×	15 0.1×	334 1.8×	58	1.2k
H Yabuuchi Japan	18	125 0.3×	198 0.5×	201 0.7×	53 0.3×	67 0.4×	55	805
Stella Liong Australia	21	75 0.2×	423 1.0×	217 0.7×	40 0.2×	311 1.7×	49	1.0k
Sandip Bhattacharyya United States	16	66 0.2×	342 0.8×	279 0.9×	9 0.0×	481 2.6×	24	1.1k
Tobias Rogosch Germany	11	126 0.3×	103 0.2×	234 0.8×	18 0.1×	488 2.7×	26	957
L. Edward Clemens United States	14	64 0.1×	64 0.1×	306 1.0×	13 0.1×	182 1.0×	19	821

Countries citing papers authored by Diane Copeland

Since Specialization

Citations

This map shows the geographic impact of Diane Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Copeland more than expected).

Fields of papers citing papers by Diane Copeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Copeland. The network helps show where Diane Copeland may publish in the future.

Co-authorship network of co-authors of Diane Copeland

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Copeland. A scholar is included among the top collaborators of Diane Copeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Copeland. Diane Copeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cabrera-Salazar, Mario A., Scott D. Bercury, Lingyun Li, et al.. (2012). Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease. PLoS ONE. 7(8). e43310–e43310. 64 indexed citations

Nietupski, Jennifer B., Joshua Pacheco, Wei‐Lien Chuang, et al.. (2012). Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice. Molecular Genetics and Metabolism. 105(4). 621–628. 54 indexed citations

Ashe, Karen M., Dinesh S. Bangari, Lingyun Li, et al.. (2011). Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease. PLoS ONE. 6(6). e21758–e21758. 57 indexed citations

Silberstein, Claudia, Elsa Zotta, Diane Copeland, et al.. (2011). A Glucosylceramide Synthase Inhibitor Protects Rats Against the Cytotoxic Effects of Shiga Toxin 2. Pediatric Research. 69(5 Part 1). 390–394. 32 indexed citations

Marshall, John, Karen M. Ashe, Dinesh S. Bangari, et al.. (2010). Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease. PLoS ONE. 5(11). e15033–e15033. 62 indexed citations

Marshall, John, Wei‐Lien Chuang, Elizabeth Hutto, et al.. (2010). Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy. Journal of Inherited Metabolic Disease. 33(3). 281–289. 39 indexed citations

Marshall, John, Karen M. Ashe, Jennifer B. Nietupski, et al.. (2010). 90. Efficacy of Genz-529468-mediated inhibition of glucosylceramide synthase in a mouse model of Sandhoff disease. Molecular Genetics and Metabolism. 99(2). S26–S26. 1 indexed citations

Zhao, Hongmei, Malgorzata Przybylska, Jinhua Zhang, et al.. (2009). Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #. Hepatology. 50(1). 85–93. 77 indexed citations

Wennekes, Tom, Alfred J. Meijer, Albert K. Groen, et al.. (2009). Dual-Action Lipophilic Iminosugar Improves Glycemic Control in Obese Rodents by Reduction of Visceral Glycosphingolipids and Buffering of Carbohydrate Assimilation. Journal of Medicinal Chemistry. 53(2). 689–698. 84 indexed citations

10.

Silberstein, Claudia, et al.. (2009). A Glucosylceramide Synthase Inhibitor Prevents the Cytotoxic Effects of Shiga Toxin-2 on Human Renal Tubular Epithelial Cells. 1(1). 71–75. 15 indexed citations

11.

Fung, John J., Craig Siegel, Elizabeth Hutto, et al.. (2007). A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Molecular Genetics and Metabolism. 91(3). 259–267. 132 indexed citations

12.

Siegel, Craig, Jenny N. Fung, Elizabeth Hutto, et al.. (2007). 24 Genz-112638: A novel orally available ceramide-based inhibitor of glucosylceramide synthase for treating Gaucher disease. Molecular Genetics and Metabolism. 92(4). 17–17. 1 indexed citations

13.

Fung, John J., et al.. (2004). Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay. Analytical Biochemistry. 334(2). 227–233. 6 indexed citations

14.

Zheng, Yun‐Ling, Dong Zhen, Stanley M. Berry, et al.. (1997). Search for the optimal fetal cell antibody: results of immunophenotyping studies using flow cytometry. Human Genetics. 100(1). 35–42. 39 indexed citations

15.

Romero, Roberto, Moshe Mazor, Waldo Sepúlveda, et al.. (1992). Tumor necrosis factor in preterm and term labor. American Journal of Obstetrics and Gynecology. 166(5). 1576–1587. 318 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact